Department of Neurology, University Hospital of Münster, Albert-Schweitzer-Campus 1, Building A1, 48149, Münster, Germany.
Orphanet J Rare Dis. 2018 Jun 5;13(1):91. doi: 10.1186/s13023-018-0833-3.
Niemann-Pick disease type C (NP-C) is a rare, progressive neurodegenerative disease caused by mutations in the NPC1 or the NPC2 gene. Neurocognitive deficits are common in NP-C, particularly in patients with the adolescent/adult-onset form. As a disease-specific therapy is available, it is important to distinguish clinically between the cognitive profiles in NP-C and primary dementia (e.g., early Alzheimer's disease; eAD).
In a prospective observational study, we directly compared the neurocognitive profiles of patients with confirmed NP-C (n = 7) and eAD (n = 15). All patients underwent neurocognitive assessment using dementia screening tests (mini-mental status examination [MMSE] and frontal assessment battery [FAB]) and an extensive battery of tests assessing verbal memory, visuoconstructive abilities, visual memory, executive functions and verbal fluency.
Overall cognitive impairment (MMSE) was significantly greater in eAD vs. NP-C (p = 0.010). The frequency of patients classified as cognitively 'impaired' was also significantly greater in eAD vs. NP-C (p = 0.025). Patients with NP-C showed relatively preserved verbal memory, but frequent impairment in visual memory, visuoconstruction, executive functions and in particular, verbal fluency. In the eAD group, a wider profile of more frequent and more severe neurocognitive deficits was seen, primarily featuring severe verbal and visual memory deficits along with major executive impairment. Delayed verbal memory recall was a particularly strong distinguishing factor between the two groups.
A combination of detailed yet easy-to-apply neurocognitive tests assessing verbal memory, executive functions and verbal fluency may help distinguish NP-C cases from those with primary dementia due to eAD.
尼曼-匹克病 C 型(NP-C)是一种由 NPC1 或 NPC2 基因突变引起的罕见、进行性神经退行性疾病。NP-C 患者常见认知功能障碍,尤其是青少年/成年起病患者。由于有特定疾病的治疗方法,因此重要的是要在临床上区分 NP-C 和原发性痴呆(例如早发性阿尔茨海默病;eAD)的认知特征。
在一项前瞻性观察研究中,我们直接比较了确诊的 NP-C 患者(n=7)和 eAD 患者(n=15)的神经认知特征。所有患者均接受了神经认知评估,包括痴呆筛查测试(简易精神状态检查[MMSE]和额叶评估量表[FAB])和一系列测试,评估言语记忆、视空间能力、视觉记忆、执行功能和言语流畅性。
eAD 患者的整体认知障碍(MMSE)明显大于 NP-C 患者(p=0.010)。认知“受损”患者的频率在 eAD 患者中也明显高于 NP-C 患者(p=0.025)。NP-C 患者的言语记忆相对保留,但视觉记忆、视空间能力、执行功能,特别是言语流畅性频繁受损。在 eAD 组中,发现了更广泛的、更频繁和更严重的神经认知缺陷,主要表现为严重的言语和视觉记忆缺陷以及主要的执行功能障碍。言语记忆延迟是两组之间的一个特别强的区分因素。
一系列详细但易于应用的神经认知测试,评估言语记忆、执行功能和言语流畅性,可能有助于区分 NP-C 病例和原发性痴呆病例,特别是由 eAD 引起的病例。